PKA(蛋白激酶A)

Cat.No. 产品名称 Information

GC65303 Jaspamycin

GC64460 8-Chloro-cAMP

GC63176 Rp-cAMPS sodium salt

GC49440 ML-9 A PKB/Akt inhibitor

GC49265 PKI (14-22) amide (myristoylated) (trifluoroacetate salt) A PKA inhibitor

GC61849 PKI 14-22 amide,myristoylated TFA

GC61747 Sp-cAMPS

GC61512 PKA Inhibitor Fragment (6-22) amide TFA A synthetic peptide inhibitor of PKA

GC60037 A-3 hydrochloride A-3 hydrochloride, a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases, againsts cAMP-dependent protein kinase (PKA) (Ki=4.3 ?M), casein kinase II (CK2) (Ki=5.1 ?M) and myosin light chain kinase (MLCK) (Ki=7.4 ?M), also inhibits Protein Kinase C (PKC) and casein kinase I (CK1) with Ki values of 47 ?M and 80 ?M, respectively.

GC50502 RI-STAD 2 AKAP disruptor; selectively binds PKA-RI with high affinity and blocks its interaction with AKAP; cell permeable

GC50501 STAD 2 STAD 2 是 PKA-RII 的有效选择性破坏剂，Kd 为 6.2 nM。

GC50407 st-Ht31 P Negative control for st-Ht31

GC50406 st-Ht31 Inhibits PKA/AKAP interactions; cell permeable

GC50181 CW 008 PKA signaling activator; promotes osteogenesis from hMSCs

GC36391 Kemptide Phospho-Ser5

GC35565 Bucladesine calcium salt

GC35518 Bilobetin A biflavonoid with diverse biological activities

GC44853 Rp-8-CPT-Cyclic AMP (sodium salt) A PKA inhibitor

GC44653 PKA Inhibitor (5-24) A synthetic peptide inhibitor of PKA

GC33771 Metadoxine Metadoxine (Metadoxil, Metasin, pyridoxine-pyrrolidone carboxylat), also known as pyridoxine-pyrrolidone carboxylate, is a drug used to treat chronic and acute alcohol intoxication. Metadoxine is a novel 5-HT2B receptor antagonist with a possible therapeutic role in treating ADHD.

GC31525 CREBtide

GC30857 Warangalone (Scandenolone)

GC30545 Malantide

GC19396 H 89 A PKA inhibitor

GC19090 CCG215022 A GRK inhibitor

GC15352 8-CPT-Cyclic AMP (sodium salt) A cell-permeable cAMP analog

GC16678 UCN-02 A PKC inhibitor

GC12799 H-8 (hydrochloride) A potent, nonspecific kinase inhibitor

GC13640 Kemptide A PKA substrate

GC10428 Sp-5,6-dichloro-cBIMPS (sodium salt) A selective PKA activator

GC11605 C-1 C-1 是一种有效的蛋白激酶抑制剂，IC50 为 4 μM, 8 μM, 12 μM 和 240 μM 用于 cGMP 依赖性蛋白激酶 (PKG)、cAMP 依赖性蛋白激酶 (PKA) ，分别为蛋白激酶 C (PKC) 和 MLC 激酶。 C-1 也用作 ROCK 抑制剂。

GC11362 K 252a A non-selective PKC inhibitor

GC17346 KT 5823 Potent selective inhibitor of cGMP-dependent protein kinase (PKG)

GC17712 AT13148 A multi-AGC kinase inhibitor

GC12321 PKI 14-22 amide, myristoylated A PKA inhibitor

GC15525 cGMP Dependent Kinase Inhibitor Peptide A cGMP-dependent protein kinase inhibitor

GC10941 cAMPS-Rp, triethylammonium salt A non-hydrolyzable analog of cAMP

GC14648 KT 5720 A potent inhibitor of PKA

GC12824 Dibutyryl-cAMP, sodium salt A cell-permeable, cAMP analog

GC16929 8-Bromo-cAMP, sodium salt A PKA activator

GC13869 Fasudil Fasudil (HA-1077; AT877) 是一种非特异性 RhoA/ROCK 抑制剂，对蛋白激酶也有抑制作用，对 ROCK1 的 Ki 为 0.33 μM，对 ROCK2 和 PKA 的 IC50 分别为 0.158 μM 和 4.58 μM、12.30 μM、1.650 μM ，PKC，PKG，分别。 Fasudil 也是一种有效的 Ca2+ 通道拮抗剂和血管扩张剂。

GC10074 H 89 2HCl A PKA inhibitor

GC14289 Fasudil (HA-1077) HCl Fasudil (HA-1077; AT877) Hydrochloride is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μ ;M, 1.650 μM 分别代表 ROCK2 和 PKA、PKC、PKG。 Fasudil (HA-1077) HCl 也是一种有效的 Ca2+ 通道拮抗剂和血管扩张剂。

GC12297 AT7867 A potent and orally bioavailable pan-Akt inhibitor

GC17255 Gliotoxin An immunosuppressive mycotoxin with diverse biological effects

GC10918 AT7867 dihydrochloride A potent and orally bioavailable pan-Akt inhibitor

GN10336 Daphnetin A coumarin derivative with diverse biological activities

GC15299 Staurosporine(CGP 41251) A potent inhibitor of protein kinase C

GP10075 PKA inhibitor fragment (6-22) amide

A synthetic peptide inhibitor of PKA